{{Rsnum
|rsid=10211524
|Chromosome=2
|position=64980940
|Orientation=plus
|GMAF=0.3921
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 18.9 | 52.3 | 28.8
| HCB | 65.0 | 31.4 | 3.6
| JPT | 52.2 | 45.1 | 2.7
| YRI | 49.0 | 42.9 | 8.2
| ASW | 35.1 | 47.4 | 17.5
| CHB | 65.0 | 31.4 | 3.6
| CHD | 73.4 | 22.0 | 4.6
| GIH | 9.1 | 45.5 | 45.5
| LWK | 36.7 | 53.2 | 10.1
| MEX | 46.6 | 41.4 | 12.1
| MKK | 0.0 | 0.0 | 0.0
| TSI | 21.6 | 46.1 | 32.4
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=22916037
  |Trait=Metabolite levels
  |Title=Novel Loci for metabolic networks and multi-tissue expression studies reveal genes for atherosclerosis.
  |RiskAllele=
  |Pval=3E-10
  |OR=NR
  |ORtxt=NR
  |OA=1
}}

{{PMID Auto
|PMID=18638388
|Title=Association study of polymorphisms in the neutral amino acid transporter genes SLC1A4, SLC1A5 and the glycine transporter genes SLC6A5, SLC6A9 with schizophrenia.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}